Measuring the economic returns from successful NASA life sciences technology transfers.
Since 1958 NASA has invested approximately $3.7 billion in life sciences R&D in the support of the successful human space flight program. There are numerous studies documenting the spin-off technologies that can be traced to NASA research and development activities. Most of these studies describe the technologies and their uses; however only a few measure the economic impact of the spin-offs and most of these are benefit/cost studies that tend to overstate benefits or underestimate costs. This study takes a different approach, measuring only economic impacts to the companies that developed successful spin-off products from NASA life sciences investments. A personal interview was conducted with each company and the benefits are conservatively estimated as the value-added by the NASA technology to the company's output and the amount of additional private R&D stimulated by the NASA R&D. This pilot study of fifteen companies, using a very conservative measurement technique, found a large return to companies that have successfully commercialized NASA life sciences spin-off products. Value-added benefits totaled over $1.5 billion and a NASA R&D total investment in these 15 technologies of $64 million was found to stimulate an additional $200 million in private R&D. The study also found that the largest benefits were from products developed and marketed by large companies, primarily because these companies had the financial and marketing resources to work on a scale unavailable to smaller companies. Many of the small companies reported very profitable product-lines as well as documented evidence of benefits extending to the commercial users of their products. However, the smaller companies often lacked either the ability or the desire to expand into much larger scale production. NASA and other government technology transfer programs may be overlooking an opportunity to enlarge the economic benefits from their spin-off technologies. When a federal R&D grant or contract ends, the formal relationship between the agency and the company also usually ends. However, the companies continue to use the prior connection to NASA for advertising and for developing new business partners. One recommendation of this study is for NASA to be more proactive with "alumni" companies and to help open additional financial and marketing doors for these companies.
Elliott School of International Affairs, Center for International Science and Technology Policy, Space Policy Institute, George Washington University, Washington, D.C. 20052, USA. hrh@gwu.edu
Henry R
HR
Hertzfeld
D001690:Biological Science Disciplines / Q000191:economics* / Q000639:trends; D009316:National Institutes of Health (U.S.); D017149:Private Sector; D012106:Research / Q000191:economics* / Q000639:trends; D013026:Space Flight / Q000191:economics* / Q000639:trends; D018581:Technology Transfer; D014481:United States; D018557:United States National Aeronautics and Space Administration / Q000191:economics* / Q000639:trends; D014893:Weightlessness